Many people who take glucagon-like peptide-1 (GLP-1) medications, such as semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound), experience significant weight loss and improvements in their cardiometabolic health. However, research suggests that when these medications are stopped, most people regain the lost weight within a relatively short period of time.
A recent study published in The BMJ reviewed data from 37 studies involving over 9,000 adults with overweight or obesity who took GLP-1 medications for at least 8 weeks. The researchers found that participants lost an average of 18 pounds while on medication, but regained this weight at a rate of about 1 pound per month after stopping treatment.
Within an average of approximately 1.7 years, most participants had regained all of their lost weight. This trend was observed across various GLP-1 medications, including newer drugs like semaglutide and tirzepatide, which were associated with a faster rate of regain.
The Importance of Comprehensive Weight Management
These findings highlight the need for a more comprehensive approach to weight management. While GLP-1 medications can be effective in the short-term, they are not a long-term solution on their own. To achieve lasting weight loss and improve overall health, it is essential to incorporate supportive changes in diet, exercise, and lifestyle.
Our team of healthcare professionals at [Clinic Name] can help you develop a personalized weight management plan that addresses your unique needs and goals. Contact us today to schedule an appointment and take the first step towards achieving a healthier, more sustainable weight loss.
Learn more about hair transplant at Rubenhair clinic.
Get a Free Consultation
Consult with our specialists about FUE procedure, PRP therapy or hair transplant.
